Company Overview

Business Description

Sector
Financials
Industry
Financial Services
Headquarters
United Kingdom UK
Employees
64
IPO date
Oct 15, 2003

IP Group PLC backs and builds companies around research from universities and other science sources, especially in the UK. It looks for early-stage ideas in fields like life sciences, technology, and deep science, then helps turn them into stand-alone businesses. In simple terms, it acts as a bridge between lab research and commercial products.

The company makes money mainly by owning shares in the spinouts and start-ups it helps create, and sometimes by providing management support or other services around those businesses. Its main customers are not ordinary consumers but universities, researchers, and the young companies themselves. For investors, the key point is that IP Group is less like a traditional product seller and more like a long-term owner of science-based ventures.

What makes its model different is that it focuses on intellectual property rather than factories or retail outlets. It tries to identify promising research early, help shape it into a company, and then benefit if those businesses grow, get licensed, or are sold. That gives IP Group a portfolio-style business tied to the success of technology transfer and scientific commercialization.

IP Group PLC Investor Relations

Address
2nd Floor, 3 Pancras Square, King's Cross
London
United Kingdom

Business Segments

Portfolio investing

IP Group puts capital into early-stage science and technology companies, often spinouts from universities and research groups, and helps them grow toward commercial products and services.

Customers and revenue model

Fund management

Through its Parkwalk business, IP Group manages specialist investment funds that place money into university spinouts and other research-led businesses.

Customers and revenue model

Management

Mr. Gregory Simon Smith A.C.A.

CEO & Executive Director

Biography unavailable

Mr. David Graham Baynes

COO, CFO, Executive Director & Operating Officer

Biography unavailable

Mr. Eoin Murphy

Group Head of IT & Operations

Biography unavailable

Ms. Angela Leach

General Counsel & Company Secretary

Biography unavailable

Ms. Helen Redmond

Senior Compliance & Risk Manager

Biography unavailable

Ms. Liz Vaughan-Adams

Director of Communications

Biography unavailable

Mr. Anthony York

Group People Director

Biography unavailable

Mr. Stuart Thompson

Talent Partner & Head of IP Exec

Biography unavailable

Dr. Mark Alexander Reilly Ph.D.

Managing Partner

Biography unavailable

Dr. Samuel Cameron Williams M.A., Ph.D.

Managing Partner, Head of Life Sciences, Managing Partner of Life Sciences & Board Observer

Biography unavailable

1 / 10